Predictive biomarkers in diffuse gliomas and non-small cell lung cancer

David P Bartel, MicroRNAs: Genomics, Biogenesis, Mechanism, and Function Cell. ,vol. 116, pp. 281- 297 ,(2004) , 10.1016/S0092-8674(04)00045-5

William D. Travis, WHO classification of tumours of the lung, pleura, thymus and heart International Agency for Research on Cancer. ,(2015)

Masakuni Serizawa, Yasuhiro Koh, Hirotsugu Kenmotsu, Mitsuhiro Isaka, Haruyasu Murakami, Hiroaki Akamatsu, Keita Mori, Masato Abe, Isamu Hayashi, Tetsuhiko Taira, Tomohiro Maniwa, Toshiaki Takahashi, Masahiro Endo, Takashi Nakajima, Yasuhisa Ohde, Nobuyuki Yamamoto, Assessment of mutational profile of Japanese lung adenocarcinoma patients by multitarget assays: A prospective, single-institute study Cancer. ,vol. 120, pp. 1471- 1481 ,(2014) , 10.1002/CNCR.28604

Sven Perner, Patrick L Wagner, Francesca Demichelis, Rohit Mehra, Christopher J LaFargue, Benjamin J Moss, Stefanie Arbogast, Alex Soltermann, Walter Weder, Thomas J Giordano, David G Beer, David S Rickman, Arul M Chinnaiyan, Holger Moch, Mark A Rubin, EML4-ALK Fusion Lung Cancer: A Rare Acquired Event Neoplasia. ,vol. 10, pp. 298- 302 ,(2008) , 10.1593/NEO.07878

Hope E. Karnes, Eric J. Duncavage, Cory T. Bernadt, Targeted next-generation sequencing using fine-needle aspirates from adenocarcinomas of the lung. Cancer Cytopathology. ,vol. 122, pp. 104- 113 ,(2014) , 10.1002/CNCY.21361

Michael P. Gailey, Aaron A. Stence, Chris S. Jensen, Deqin Ma, Multiplatform comparison of molecular oncology tests performed on cytology specimens and formalin-fixed, paraffin-embedded tissue. Cancer Cytopathology. ,vol. 123, pp. 30- 39 ,(2015) , 10.1002/CNCY.21476

Xuchao Zhang, Shirley Zhang, Xuening Yang, Jinji Yang, Qing Zhou, Lucy Yin, Shejuan An, Jiaying Lin, Shiliang Chen, Zhi Xie, Mike Zhu, Xiaolin Zhang, Yi-long Wu, Fusion of EML4 and ALK is associated with development of lung adenocarcinomas lacking EGFR and KRAS mutations and is correlated with ALK expression. Molecular Cancer. ,vol. 9, pp. 188- 188 ,(2010) , 10.1186/1476-4598-9-188

J. Gregory Cairncross, Meihua Wang, Robert B. Jenkins, Edward G. Shaw, Caterina Giannini, David G. Brachman, Jan C. Buckner, Karen L. Fink, Luis Souhami, Normand J. Laperriere, Jason T. Huse, Minesh P. Mehta, Walter J. Curran, Benefit From Procarbazine, Lomustine, and Vincristine in Oligodendroglial Tumors Is Associated With Mutation of IDH Journal of Clinical Oncology. ,vol. 32, pp. 783- 790 ,(2014) , 10.1200/JCO.2013.49.3726

Justin F. Gainor, Anna M. Varghese, Sai-Hong Ignatius Ou, Sheheryar Kabraji, Mark M. Awad, Ryohei Katayama, Amanda Pawlak, Mari Mino-Kenudson, Beow Y. Yeap, Gregory J. Riely, A. John Iafrate, Maria E. Arcila, Marc Ladanyi, Jeffrey A. Engelman, Dora Dias-Santagata, Alice T. Shaw, ALK Rearrangements Are Mutually Exclusive with Mutations in EGFR or KRAS: An Analysis of 1,683 Patients with Non–Small Cell Lung Cancer Clinical Cancer Research. ,vol. 19, pp. 4273- 4281 ,(2013) , 10.1158/1078-0432.CCR-13-0318

Rebecca S. Finley, Overview of targeted therapies for cancer. American Journal of Health-system Pharmacy. ,vol. 60, ,(2003) , 10.1093/AJHP/60.SUPPL_9.S4